Rethinking the immune recognition of cell walls in human fungal pathogens: Mechanisms, controversies and translational significance Authors: Rong Wang, Xiaoyu Peng, Wenqing Liu, Zhangyong Song, Hong Yu Published: 2026 ABSTRACT ABSTRACTFungal cell wall polysaccharides – such as β-glucans, chitin, and mannans – are key immunogenic structures recognized by Toll-like receptors and C-type lectin receptors on innate immune cells, initiating phagocytosis, cytokine production, and antigen presentation, and shaping downstream adaptive immunity. CD4+ T cells differentiate into Th1, Th2, Th17, and Treg subsets to maintain immune balance, whereas B cells contribute to fungal clearance and memory through species-specific antibodies. The boundary between protective and pathogenic immunity varies with fungal species, infection stage, and host immune status, collectively influencing PRR signaling and lymphocyte effector outcomes. This review summarizes recognition mechanisms, signaling pathways, and immunoregulatory roles of immune cells in response to fungal cell wall polysaccharides, highlighting the dual roles of innate and adaptive immunity in antifungal defense and immunopathology, and discussing current controversies, knowledge gaps, and prospects for immunomodulatory and vaccine-based antifungal strategies.KEYWORDS: Immune cell, pattern recognition receptor, fungal cell wall polysaccharides, immunotherapy, immune response Introduction Over the past decade, the global burden of invasive fungal infections (IFIs) has continued to rise, becoming a major public health concern worldwide. Invasive medical procedures, immunosuppressive therapies, and elderly individuals with immunosenescence, co-morbidities, or frequent use of immunosuppressive medications all significantly increase host susceptibility to opportunistic fungal infections [1,2]. In addition, during and after the COVID-19 pandemic, reports of fungal co-infections in patients with coronavirus disease 2019 (COVID-19) have increased significantly, further exposing the fragility of current diagnostic and therapeutic strategies [3,4]. Meanwhile, the emergence of multidrug-resistant fungi such as Candida auris, characterized by strong resistance and immune evasion capacity [5], underscores the practical limitation of relying solely on conventional antifungal drugs for long-term control of fungal diseases. The fungal cell wall represents the first interface of contact between pathogens and the host immune system and serves as a critical structural basis determining the outcome of infection. Unlike relatively stable immunostimulatory molecules such as bacterial lipopolysaccharide, the fungal cell wall exhibits remarkable complexity and dynamic plasticity. It is primarily composed of chitin, β-glucan, mannan, and glycoproteins, which collectively maintain fungal cell morphology, mechanical integrity, and environmental adaptability [6]. Meanwhile, the fungal cell wall is not a static structure but undergoes continuous remodeling in response to different developmental stages, environmental stresses, and host infection conditions, thereby altering the exposure of immune-related surface molecules. For example, the rodlet layer and DHN-melanin layer on the surface of dormant conidia of Aspergillus fumigatus can reduce the exposure of immune-recognition-related components, whereas the polysaccharide capsule produced by Cryptococcus can modulate host defense responses through physical masking and immune regulation [7,8]. Therefore, host immune recognition is not solely determined by the chemical composition of the fungal cell wall, but rather by the integrated effects of cell wall architecture, spatial exposure patterns, and dynamic remodeling, which collectively define the “immune visibility” of fungal pathogens. The host immune system can sense fungal cell wall components through multiple pattern recognition receptors (PRRs) and initiate coordinated antifungal immune responses. Innate immune cells recognize fungal cell wall-associated pathogen-associated molecular patterns (PAMPs) through C-type lectin receptors (CLRs), Toll-like receptors (TLRs), and the complement system, thereby inducing phagocytosis, the release of inflammatory mediators, and the activation of multiple signaling pathways. These processes further contribute to the regulation of adaptive immune response development and the establishment of immune memory [9]. In addition to classical immune cells, epithelial cells of the airway and gastrointestinal tract also participate in fungal sensing and the regulation of inflammatory responses, thereby playing a crucial bridging role in host defense, immune tolerance, and the development of allergic reactions [10–12]. Moreover, the complement system, as an essential component of innate immunity, can directly interact with fungal cell wall polysaccharides and cooperate with PRRs to promote phagocytosis and amplify inflammatory responses. The magnitude of complement activation is also significantly influenced by fungal species and the degree of cell wall component exposure [13]. However, fungi employ multiple strategies – including cell wall remodeling, glycan masking, and signal interference – to escape from immune detection [14,15]. Consequently, the integration of PRR-mediated signaling and intercellular communication exhibits high heterogeneity across fungal species, infection stages, and host contexts. The emerging concept of “trained immunity,” along with recent advances in memory T and B cell research, suggests that coordinated interactions between innate and adaptive immunity may provide novel avenues for broad and durable antifungal protection [16]. Nevertheless, the feasibility and temporal regulation of these mechanisms in clinically relevant models remain unclear. Based on this background, this review systematically summarizes the chemical and structural characteristics of major fungal cell wall components, the signaling pathways and cellular effects triggered by their recognition through host PRRs, and the resulting innate and adaptive immune responses and immune memory. Furthermore, this review critically evaluates current methodological limitations and knowledge gaps – including the mechanisms of PRR signal integration, immune cell functional heterogeneity, and the challenges in immune training and vaccine translation – and proposes future research and translational directions to provide a theoretical foundation for antifungal immunotherapy and vaccine design. The structure, remodeling and immune evasion of fungal cell walls The structure of fungal cell walls The fungal cell wall is a highly organized and dynamically remodeled three-dimensional polysaccharide network, whose composition varies markedly depending on fungal species, growth stage, and environmental conditions. The major structural components include glucans (such as α-1,3-, β-1,3-, and β-1,6-glucans), mannans, and chitin, while glycoproteins constitute only a small proportion [17] (Figure 1). Together, these components determine the rigidity, elasticity, and immunological properties of the cell wall. Recent studies have shown that although different pathogenic fungi, such as A. fumigatus, Candida albicans, and Cryptococcus neoformans, are phylogenetically distant and exhibit substantial differences in their outer cell wall components and spatial architectures, their cell walls generally retain conserved core structures represented by β-glucan, chitin, and mannan [8]. Increasing evidence indicates that these shared structural components alone are insufficient to determine fungal pathogenicity. Instead, different fungal pathogens regulate host pattern recognition receptor-mediated sensing through dynamic cell wall remodeling, modulation of the exposure or masking of surface pathogen-associated molecular patterns, and regulation of species-specific cell wall components, thereby influencing immune activation, immune evasion, and disease progression. Therefore, a comprehensive understanding of the dynamic alterations in fungal cell wall composition and their immune regulatory mechanisms is essential for elucidating host–pathogen interactions and the development of virulence among different pathogenic fungi. For example, C. albicans extends the α-1,6-mannan backbone to weaken host Dectin-1 receptor recognition of β-glucans, thereby enhancing its immune evasion capacity [18]. This process is particularly pronounced during the transition from the yeast form to the hyphal form and represents one of the key molecular bases underlying the shift from a commensal to a pathogenic state. The cell wall of A. fumigatus contains a relatively high proportion of chitin (up to approximately 15%), which is closely associated with β-1,3-glucan to maintain cell wall stability, thereby enhancing its mechanical strength and resistance [19,20]. Notably, during spore germination and hyphal growth, the fungal cell wall undergoes pronounced remodeling, leading to the progressive exposure of β-glucans, which in turn enhances host PRR–mediated immune recognition [21]. Cryptococcus possesses a distinct cell surface architecture that differs from those of other major pathogenic fungi. Its outermost layer is composed of a thick polysaccharide capsule, primarily consisting of glucuronoxylomannan (GXM) and galactoxylomannan (GalXM), which represents a critical structural determinant of its virulence [22]. The capsule is attached to the surface of the cell wall, which is composed of α-glucan, β-glucan, chitin, chitosan, and mannoproteins, and together they form a continuous cell surface structure [23]. Recent studies have demonstrated that the cell wall not only maintains cellular morphology and mechanical integrity but also participates in capsule biosynthesis, organization, and stable anchoring [24]. Among these components, β-(1,6)-glucan promotes the organization and integrity of the cell wall structure by mediating cross-linking between cell wall polysaccharides and glycoproteins [25]. Meanwhile, capsular polysaccharides effectively mask immune-recognition-related components [26] and facilitate immune evasion through multiple mechanisms, including inhibition of phagocytosis [27], modulation of inflammatory responses, and interference with antigen presentation [28]. Therefore, the integrated cell wall–capsule structure is considered a fundamental basis for Cryptococcus adaptation to the host environment and maintenance of its virulence. Similarly, during the transition from the environmental to the pathogenic form, Histoplasma and Paracoccidioides undergo substantial cell wall remodeling, characterized by a reduction in β-glucan content and a concomitant increase in α-glucans. This shift diminishes host PRRs activation and is regarded as an important mechanism facilitating adaptation to an intracellular parasitic lifestyle [29,30]. Schematic representation of the fungal cell wall architecture and its dynamic organization. the fungal cell wall is a multilayered and highly dynamic structure primarily composed of mannans, chitin, and glucans. The outer layer is enriched in mannoproteins, in which mannans are covalently linked to proteins to form mannoproteins that mediate host–pathogen interactions and immune recognition. Beneath this layer, β-glucans (mainly β-1,3-glucan with β-1,6 branches) constitute the core structural network. Chitin is arranged in an antiparallel manner and cross-linked with β-1,3-glucan to form a rigid, basket-like scaffold that provides mechanical strength and maintains cell integrity. Notably, the spatial organization and exposure of these components are dynamically remodeled in response to environmental cues and host immune pressure, thereby influencing immune recognition and fungal pathogenicity. Although substantial progress has been made in understanding the chemical composition and spatial distribution of the major components of fungal cell walls, significant differences remain in the composition, spatial exposure, and dynamic remodeling of cell wall components among different fungal genera and even within the same species under distinct growth states, such as yeast, hyphal, or biofilm forms. This structural heterogeneity not only determines the efficiency of host PRRs in sensing PAMPs, but also influences fungal susceptibility to antifungal agents. For example, during exposure to echinocandins, fungi can induce compensatory chitin synthesis and cell wall remodeling to partially counteract the cell wall damage caused by inhibition of β-(1,3)-glucan synthesis, thereby reducing antifungal susceptibility [31]. Therefore, a comprehensive understanding of the dynamic heterogeneity of fungal cell wall structures and the underlying regulatory mechanisms is not only essential for elucidating host immune recognition processes but also provides an important foundation for the development of novel antifungal therapeutic strategies targeting the fungal cell wall. Moreover, quantitative studies on polysaccharide composition under different fungal species, morphologies, and growth conditions are still limited. Most current literature relies on in vitro models or structural predictions, lacking integrated biochemical and immunological analyses. This limitation hampers a comprehensive understanding of the causal relationship between specific polysaccharide alterations and immune evasion phenotypes. Dynamic change and reshaping mechanism The fungal cell wall exhibits remarkable plasticity and remodeling capacity, enabling fungi to survive and proliferate under fluctuating host environments and antifungal drug pressure. Recent studies have revealed that cell wall remodeling serves as a key adaptive strategy for fungi in response to antifungal drug stress. For example, in A. fumigatus, treatment with echinocandins inhibits β-1,3-glucan synthesis, while the structural association between α-1,3-glucan and chitin is significantly enhanced, thereby helping to maintain cell wall integrity and increasing its tolerance [21]. Such findings indicate that cell wall remodeling is one of the major mechanisms underlying fungal drug resistance. However, most current studies are based on in vitro culture systems or single-strain models, and it remains unclear whether these remodeling mechanisms are equally prevalent during in vivo infection. Future studies should integrate animal infection models with longitudinal analyses of clinically collected specimens to validate the causal relationship between drug-induced cell wall remodeling and resistant phenotypes. In addition, cell wall remodeling directly influences fungal pathogenicity. For instance, β-glucans in the cell wall of certain Aspergillus sydowii species can activate host inflammatory responses via the Dectin-1/Caspase recruitment domain-containing protein 9 (CARD9) signaling pathway, such as promoting the secretion of interleukin-1β (IL-1β) [32]. Although this mechanism contributes to host defense, some studies suggest that, under specific conditions, such inflammation may exacerbate pulmonary lesions or even promote tumor progression [32], highlighting the “double-edged sword” nature of fungal polysaccharide–host signaling interactions. It should be noted that A. sydowii is not a typical human pathogenic fungus. Although it has been detected in tumor tissues, there is currently no evidence to suggest that it can directly cause invasive infections. It should be noted that most of these findings are derived from murine models, and inflammatory responses may vary among species and infection contexts; therefore, extrapolation to humans should be approached with caution. Moreover, fungal intrinsic homeostatic mechanisms are also tightly linked to cell wall remodeling. In C. neoformans, the autophagy pathway is essential for maintaining cell wall integrity. Deletion of autophagy-related genes, such as ATG genes, impairs cell wall architecture, reduces virulence, and compromises fungal survival within the host [33]. This suggests that fungi adapt to environmental and host-derived stresses by modulating autophagy and cell wall biosynthetic networks. However, systematic understanding of the role of autophagy across different fungal species and its interplay with immune evasion mechanisms remains limited. In summary, dynamic adaptation and remodeling of the fungal cell wall are not only central to antifungal drug tolerance and pathogenicity but also may modulate host immune responses. Although key mechanisms have been identified, several unresolved controversies remain: whether antifungal drug-induced remodeling exhibits consistent patterns across fungal species and host environments; how regulatory networks and signaling pathways control the balance between β-glucan and α-glucan synthesis during remodeling; and how autophagy and other intracellular homeostatic processes cooperate to influence cell wall remodeling and immune evasion. Future research should combine in vivo infection models, dynamic structural analyses (such as in situ nuclear magnetic resonance or fluorescence-based tracking), and immunological assays to comprehensively elucidate the spatiotemporal dynamics of fungal cell wall remodeling and its implications for antifungal therapy and immune modulation strategies. Cell wall and immune escape The fungal cell wall not only plays an essential role in maintaining cellular morphology and protecting against environmental stress but also serves as the primary interface through which the host immune system recognizes invading pathogens. Accordingly, the ability to regulate the exposure of cell wall components, modify cell surface architecture, and adapt to host immune pressure has become a critical strategy by which fungi establish infection and ensure survival within the host. Increasing evidence in recent years has demonstrated that fungal cell wall-mediated immune evasion is not driven by a single mechanism but rather results from a series of coordinated processes, including antigen masking, active cell wall remodeling, and adaptive remodeling in response to the host environment. Nevertheless, current studies have focused predominantly on a limited number of model fungal species, and most available evidence has been derived from in vitro culture systems or acute infection models. Whether these mechanisms are broadly conserved and function similarly during human fungal infections remains to be further validated. Antigen masking Antigen masking represents the most direct mechanism of cell wall-mediated immune evasion, with its defining feature being the reduction of PAMP exposure, thereby decreasing the efficiency of pattern recognition receptor (PRR)-mediated recognition. As a major ligand for Dectin-1, β-(1,3)-glucan is located predominantly in the inner layer of the fungal cell wall and is partially concealed by outer-layer α-(1,3)-glucan, mannans, and glycoproteins in many fungal species, thereby limiting recognition by host immune cells [21]. In A. fumigatus, the rodlet layer and DHN-melanin covering the surface of resting conidia further mask cell wall PAMPs, thereby reducing recognition by Dectin-1 and other receptors. In addition, these surface structures inhibit phagosomal acidification and delay host immune activation, making them key contributors to immune evasion during the early stage of infection [34,35]. In Cryptococcus species, a polysaccharide capsule enriched in GXM and GalXM forms a physical barrier that masks cell wall antigens while simultaneously suppressing phagocytosis and inflammatory responses, thereby further reducing host immune recognition [22]. However, antigen masking strategies differ substantially among fungal species, and their effectiveness is influenced by multiple factors, including fungal species, developmental stage, and the host microenvironment. At present, studies investigating the dynamic exposure of fungal cell wall antigens remain limited, and direct evidence capturing their real-time changes during the course of infection is still lacking. Active remodeling of the cell wall Beyond static antigen masking, fungi can actively modulate the composition and architecture of their cell walls, enabling dynamic adaptation to host immune pressure. In C. albicans, host-associated environmental cues such as lactate and hypoxia induce the expression of cell wall remodeling enzymes, including the exo-β-glucanase Xog1, which promotes the trimming of surface-exposed β-(1,3)-glucan, thereby reducing Dectin-1-mediated recognition and subsequent inflammatory responses [22]. In addition, multiple signaling pathways involved in cell wall biosynthesis and remodeling coordinately regulate this process, allowing the cell wall architecture to be continuously adjusted in response to changes in the host environment. Increasing evidence suggests that fungal immune evasion does not rely on a single cell wall component but instead results from the coordinated interplay among environmental sensing, regulation of cell wall metabolism, and the expression of virulence factors. Although numerous mechanisms of fungal cell wall remodeling have been identified, the underlying regulatory network has not yet been fully elucidated. Furthermore, it remains unclear whether fungi employ the same remodeling strategies in different host tissues or under distinct host immune conditions, highlighting the need for more systematic investigation. Immune evasion and adaptation As infection progresses, fungi must not only evade host immune recognition but also continuously adapt to immune pressure in order to sustain long-term colonization or establish chronic infection. Accordingly, cell wall remodeling gradually shifts from a mechanism of short-term immune evasion to one that supports long-term adaptation to the host. Within the host, Cryptococcus species continuously modulate capsule thickness and polysaccharide composition in response to environmental changes. These adaptations not only enhance resistance to phagocytic cells and the complement system but also influence inflammatory cytokine production and antigen presentation, thereby promoting persistent infection [36]. In contrast, DHN-melanin in A. fumigatus is primarily associated with resting conidia and is largely lost following conidial germination and hyphal development. Consequently, its immune evasion function is mainly restricted to the early stage of infection [34,35]. By comparison, pyomelanin produced during the hyphal stage contributes predominantly to resistance against oxidative stress [37], and there is currently insufficient evidence to support a direct role for pyomelanin in mediating host immune evasion. These findings suggest that different fungal pathogens employ distinct cell wall adaptation strategies at different stages of infection. At present, most studies have focused on individual virulence factors or specific stages of infection. Consequently, a systematic understanding is still lacking regarding the dynamic changes in cell wall architecture during acute and persistent infections, as well as within tissue-specific immune microenvironments. Moreover, the feedback regulatory mechanisms between host immune pressure and fungal cell wall remodeling remain poorly understood. Overall, fungal cell wall-mediated immune evasion is a dynamic and temporally coordinated process. During the early stage of infection, fungi primarily rely on antigen masking to reduce host immune recognition. Subsequently, they actively remodel the cell wall to continuously regulate the exposure of PAMPs, thereby adapting to host immune pressure. During persistent infection, fungi further establish stable host-adaptive cell wall structures that support long-term survival. Nevertheless, several major challenges remain. First, a unified comparative framework for immune evasion mechanisms across different fungal species is still lacking. Second, most current evidence is derived from in vitro culture systems or acute infection models, providing limited insight into the dynamic changes in fungal cell wall architecture during natural infection. Third, the bidirectional regulatory network linking host immune pressure and fungal cell wall remodeling has yet to be fully elucidated. Future studies integrating in vivo real-time imaging, spatial omics, single-cell multi-omics, and high-resolution cell wall omics are expected to provide a comprehensive spatiotemporal understanding of the dynamic regulatory mechanisms underlying fungal cell wall-mediated immune evasion, thereby offering a theoretical foundation for the development of novel antifungal immunotherapeutic strategies. Emerging technologies in fungal cell wall research In recent years, the development of advanced analytical technologies has greatly advanced our understanding of the structural organization and dynamic remodeling of the fungal cell wall. Unlike conventional biochemical extraction methods and electron microscopy, which primarily rely on fixed samples, in situ nuclear magnetic resonance (in situ NMR) and solid-state nuclear magnetic resonance (solid-state NMR) enable high-resolution characterization of the spatial organization, molecular interactions, and cross-linking networks of major cell wall polysaccharides, including β-glucan, chitin, and mannan, while preserving the native architecture of the cell wall as much as possible. These techniques have therefore provided powerful tools for investigating structural remodeling of the fungal cell wall during environmental adaptation and host-associated stress [38–40]. Nevertheless, NMR-based approaches still have several limitations, including relatively low sensitivity, the requirement for large amounts of sample, complex data interpretation, and the frequent need for stable isotope labeling. Moreover, because infected tissues contain abundant host-derived components that generate substantial background signals, these techniques are currently applied mainly to fungi grown in vitro, and in situ structural analysis of fungal cell walls within infected host tissues remains technically challenging. Meanwhile, the recent development of super-resolution microscopy, including stimulated emission depletion (STED) microscopy, structured illumination microscopy (SIM), and single-molecule localization microscopy (SMLM), together with live-cell imaging, has enabled the visualization of fungal cell wall remodeling with unprecedented spatial and temporal resolution. Compared with conventional fluorescence imaging approaches, these techniques allow more precise characterization of the spatial distribution and dynamic exposure of cell wall polysaccharides during different developmental stages, in response to antifungal treatment, and under host immune pressure. Consequently, they have facilitated the investigation of the spatiotemporal heterogeneity of pathogen-associated molecular pattern (PAMP) exposure and the dynamic regulatory mechanisms governing cell wall remodeling [41,42]. Overall, these emerging technologies have not only substantially improved the structural resolution of fungal cell wall analysis but have also deepened our understanding of dynamic cell wall remodeling, the regulation of PAMP exposure, and host–pathogen interactions. More importantly, they facilitate the identification of previously unrecognized key cell wall structures and dynamic regulatory nodes, thereby providing important mechanistic insights for discovering potential antifungal drug targets, elucidating cell wall remodeling mechanisms associated with antifungal resistance, and optimizing host-directed immunomodulatory strategies, rather than directly constituting the theoretical basis for antifungal drug development itself. Epithelial cell responses to fungal cell walls Epithelial cells play an active role in antifungal defense rather than serving merely as passive physical barriers. Mucosal epithelia of the airway, gastrointestinal tract, oral cavity, and vagina are continuously exposed to environmental microorganisms and the mycobiome, and their integrity and immune responsiveness directly influence fungal colonization and invasion. Epithelial cells express a variety of PRRs that enable them to sense fungal cell wall components and damage-associated signals. Upon activation, they rapidly induce the production of inflammatory cytokines (such as IL-1, IL-8, and CCL20) and chemokines through signaling pathways including MAPK and EGFR, thereby orchestrating the recruitment and activation of neutrophils and other immune effector cells [43]. This epithelial–immune cell crosstalk represents a critical early mechanism for limiting fungal proliferation and invasion. In addition, epithelial cells secrete antimicrobial peptides (AMPs), such as β-defensins and LL-37, as well as antimicrobial proteins that not only directly inhibit fungal growth but also shape the local immune microenvironment and microbial community structure, thereby contributing to the maintenance of mucosal homeostasis and commensalism [11]. In addition to classical antimicrobial peptides, epithelial cells can secrete a variety of soluble pattern-recognition proteins (sPRPs), which constitute an important component of mucosal antifungal immunity. Among them, surfactant protein A (SP-A) and surfactant protein D (SP-D), primarily secreted by alveolar type II epithelial cells and airway epithelial cells, have been the most extensively studied. These collections recognize carbohydrate structures such as mannans and β-glucans in the fungal cell wall, thereby promoting pathogen opsonization and enhancing phagocytic clearance, while also modulating local inflammatory responses to prevent excessive immune-mediated damage [44]. Studies have shown that SP-A and SP-D can bind to a variety of fungi, including A. fumigatus, C. albicans, and C. neoformans, and enhance the phagocytic and fungicidal activities of macrophages and neutrophils [45]. In addition, soluble lectins such as mannose-binding lectin (MBL) also participate in fungal recognition and complement activation, exerting synergistic effects in early host antifungal defense. In recent years, increasing evidence suggests that these epithelial-derived soluble PRRs are not merely an extension of the physical barrier, but also form an essential component of an “innate immune coating” on mucosal surfaces. This coating plays a crucial role in limiting fungal colonization and maintaining tissue homeostasis [46]. In the airway, epithelial-derived lactoferrin and β-defensins exhibit inhibitory effects on Aspergillus spore germination and have been proposed as potential therapeutic targets. In the oral and vaginal mucosa, epithelial cell–derived AMPs and cytokines play critical roles in preventing Candida colonization and maintaining asymptomatic coexistence. Despite growing insights into fungal–epithelial interactions, significant knowledge gaps remain that limit their clinical translation. On the one hand, epithelial recognition patterns and inflammatory thresholds vary substantially across different tissues. For example, IL-17 exhibits tissue-specific roles in regulating epithelial responses to β-glucans, suggesting that epithelial-targeted immunotherapies must account for organ-specific immune environments. On the other hand, the competitive and cooperative interactions between epithelial cells and resident microbiota – including both bacteria and fungi – remain incompletely understood [47]. Their contributions to fungal overgrowth and infection under conditions of microbial dysbiosis, such as after antibiotic exposure, require further clarification. Moreover, the signaling networks linking epithelial cells to adaptive immunity and their roles in shaping immune memory represent important directions for future research. The response of innate immune cells to the cell walls of fungi Immune response of macrophages and neutrophils Macrophages and neutrophils recognize fungal cell wall components through multiple surface PRRs, including CLRs, TLRs and non-classical pattern recognition receptor Galectin-3 (Gal-3). Activation of PRRs triggers complex signaling networks that induce the pro-inflammatory and regulatory cytokine production, regulating chemotaxis, phagocytosis, and adaptive immune responses. Notably, although extensive in vitro and animal studies have elucidated PRR-mediated signaling pathways, the strength, direction, and outcomes of these signals can vary significantly across different fungal species, host microenvironments, and infection stages, indicating that our understanding of PRR functions still requires validation in more physiologically relevant contexts. Roles and controversies of CLRs in fungal infection C-type lectin receptors play a critical role in fungal recognition, with representative receptors including Dectin-1, Dectin-2, macrophage-inducible C-type lectin (Mincle) and MR. These receptors are broadly involved in fungal detection, phagocytosis, and regulation of innate immunity. Among them, Dectin-1 is one of the most extensively studied, primarily expressed on myeloid cells and dendritic cells (DCs), and recognizes β-glucans and mannans in the fungal cell wall, particularly mediating immune recognition of Aspergillus and C. albicans [48]. Dectin-1 activates downstream NF-κB and MAPK signaling, including ERK and c-Jun JNK, via the Syk-CARD9 and the Raf-1 pathway. This induces the production of pro-inflammatory cytokines such as TNF, IL-6, and IL-23, promotes DC maturation, ROS generation, and neutrophil recruitment, thereby enhancing phagocytosis and inflammatory responses [49–52]. Although this pathway is generally conserved across multiple fungal infections, the dependence of Dectin-1 signaling varies with fungal components, infection stages, and immune cell types, suggesting that its immune function exhibits context-specificity and dynamic plasticity. In recent years, Dectin-1 has attracted attention as a key receptor in trained immunity. Studies have shown that β-glucans can induce epigenetic reprogramming of monocytes and macrophages via the Dectin-1–Akt–mammalian target of rapamycin (mTOR)–hypoxia-inducible factor 1α (HIF-1α) pathway or PGNase-mediated pathways, resulting in a sustained enhanced immune state [16]. However, whether this process is entirely dependent on Dectin-1 remains controversial. Some studies suggest that β-glucan–induced trained immunity can also be mediated by other PRRs [43], indicating that the mechanism depends on the type of stimulus and cellular context. Future studies should clarify the interplay between Dectin-1 and other PRRs in trained immunity to determine its independence and synergy in innate immune memory. Notably, recent population genetics studies have demonstrated that single nucleotide polymorphisms (SNPs) in Dectin-1 and other PRRs can significantly influence host susceptibility to fungal infections and the magnitude of immune responses. For example, the well-characterized loss-of-function mutation Y238X in the CLEC7A gene impairs Dectin-1–mediated recognition of β-glucans, resulting in reduced production of cytokines such as IL-6, TNF-α, and IL-17, and is strongly associated with an increased risk of invasive candidiasis and aspergillosis [53,54]. Similarly, genetic variations in TLR2, TLR4, and pentraxins (such as PTX3) have been shown to affect innate immune activation thresholds, inflammatory intensity, and disease outcomes [55,56]. However, current studies on PRR genetic polymorphisms have largely focused on association analyses, with limited mechanistic insight into how these variants influence signal integration, cellular functional differentiation, or the establishment of immune memory. Moreover, heterogeneity in sample size, infection models, and clinical endpoints across studies has limited the comparability of findings. Therefore, future investigations integrating functional experiments with well-designed clinical cohort studies are required to systematically elucidate the biological significance of Dectin-1 and related receptor polymorphisms in antifungal immunity. Of particular note, the emerging multidrug-resistant fungus C. auris exhibits unique immune evasion strategies. By reducing surface β-glucan exposure, C. auris significantly diminishes Dectin-1–mediated recognition, phagocytosis, and Th17 responses [57]. β-glucans are only exposed following antifungal drug treatment or cell wall damage [58,59], suggesting that combined pharmacological and immune activation strategies may enhance host defense. However, understanding of C. auris immune evasion remains at an early stage, and the relationship between its Dectin-1 recognition defect and pathogenic plasticity requires further investigation. In addition, Dectin-1 is also involved in recognizing chitin and chitosan, regulating the expression of TNF-α, IL-6, and IL-17 [60,61], demonstrating its broad-spectrum role in detecting multiple fungal cell wall components. Overall, Dectin-1 is not only a core receptor for antifungal immunity but may also play a pivotal regulatory role in trained immunity and defense against drug-resistant fungi. Future research should focus on the dynamic regulation of its signaling pathways, cooperation with other PRRs, and potential combinatorial therapeutic strategies, providing a theoretical basis for novel antifungal immunotherapies and vaccine design. Dectin-2 is an important member of the CLR family, playing multiple roles in fungal infection defense, including pathogen recognition, immune activation, and cytokine regulation. This receptor is primarily expressed on the surface of Langerhans cells, neutrophils, macrophages, and dendritic cells, and is capable of recognizing α-mannan structures present on a variety of fungal surfaces. These structures exhibit differential expression and accessibility among different fungal species [59]. Notably, Dectin-2 has been reported to participate in α-mannan–related recognition or binding in fungi such as C. albicans [62], A. fumigatus [63], Saccharomyces cerevisiae [64], and C. neoformans [65]. However, its recognition efficiency is significantly influenced by fungal species, growth stage, and the degree of cell wall exposure. However, its binding capacity is modulated by Ca2+ concentration and competitive interactions with mannose [64], indicating that its recognition mechanism is dynamically variable and may limit specificity and stability in complex infection environments. In terms of signaling, Dectin-2 lacks a classical intracellular domain, and its function relies on Fc receptor γ chain (FcRγ)-mediated adaptor signaling [66,67]. Although this dependency has been confirmed, the exact mode of interaction between Dectin-2 and FcRγ remains incompletely understood. Recent studies suggest that signal transmission may occur via noncanonical interactions in the cytoplasmic proximal region, but whether this mechanism affects signal strength or downstream pathway bias requires systematic investigation [66]. Notably, the regulatory effects of Dectin-2 vary significantly across different immune cell types. Some studies indicate that Dectin-2 can promote Th17 differentiation via IL-23 induction [54]; however, this effect depends on fungal PAMP structure and the host microenvironment. Under specific conditions, Dectin-2 activation can also upregulate IL-10 or programmed death-ligand 1 (PD-L1) [68,69], suggesting that its signaling has bidirectional regulatory potential rather than purely pro-inflammatory action. This complexity highlights the critical role of Dectin-2 in balancing inflammation and immune tolerance, while also reflecting inconsistencies in current studies regarding model systems, pathogen species, and cellular contexts. Overall, the dynamic plasticity of Dectin-2 signaling provides a conceptual framework for understanding immune balance during fungal infection. Future research should focus on the mechanisms underlying its signaling bias and its cooperation with other CLRs to elucidate its precise role in immune pathophysiology and evaluate its potential as a target for immune interventions or vaccine adjuvants. Notably, in addition to receptor expression and signaling regulation, genetic polymorphisms in PRRs may also influence the strength of host immune responses to fungi. Accumulating evidence indicates that single nucleotide polymorphisms in Dectin-1, TLRs, and their downstream signaling molecules such as CARD9 are closely associated with susceptibility to invasive candidiasis, aspergillosis, and cryptococcal infection [70]. Although genetic studies on Dectin-2 (CLEC6A) remain relatively limited, its strong functional coupling with the FcRγ–CARD9 signaling axis suggests that its activity may likewise be modulated by genetic variation [71]. In addition, polymorphisms in soluble pattern recognition molecules such as pentraxins – particularly PTX3 – have been shown to affect complement activation and phagocytic efficiency, thereby indirectly regulating CLR-mediated antifungal immune responses [72]. Overall, PRR-related genetic polymorphisms provide important insights into interindividual differences in susceptibility to fungal infections. However, systematic comparative studies across different fungal species are still lacking, and further investigation in larger human cohorts and in vivo models is required to fully elucidate their biological significance. Mincle is primarily expressed on macrophages, neutrophils, and dendritic cells, recognizing α-mannan structures on fungal surfaces and being regulated by inflammatory signals [73,74]. It induces pro-inflammatory cytokine production via the Syk–NF-κB pathway, thereby maintaining local immune homeostasis [74]. Early studies suggested that Mincle plays a key role in defending against Malassezia infections [75], and its deficiency increases susceptibility to systemic Candida infections [62]. However, subsequent studies have produced inconsistent results, showing limited immune impact on Candida and Aspergillus infections [62], suggesting that its function may be partially compensated or cooperatively regulated by other CLRs. At the molecular level, Mincle mediates signaling through transmembrane arginine-mediated binding to the FcRγ chain [76]. Although the core mechanism of this pathway has been established, downstream signaling exhibits differences such as pro-inflammatory, immunosuppressive, or metabolic reprogramming effects depending on the cellular context [77,78], revealing unexplored regulatory complexity. Notably, the Mincle agonist UM-1098 can induce strong Th1/Th17 responses [79], indicating its potential in regulating adaptive immunity. However, systematic validation in natural infection models is lacking, and its direct role in T cell polarization and host defense remains unclear. Future research should focus on biased regulation of Mincle signaling and its interaction with metabolic networks to evaluate its feasibility as a target for immune intervention or vaccine adjuvants. MR is mainly expressed on specific macrophage subsets and plays a critical role in fungal recognition and immune regulation. It recognizes terminal α-(1,2)- and α-(1,3)-linked mannose residues in N-linked mannans of the fungal cell wall, mediating pathogen phagocytosis and promoting antigen presentation by dendritic cells [80]. In antifungal immunity against C. albicans, MR exhibits a clear dual function. On one hand, its activation can promote Th17 differentiation via IL-17 induction, enhancing pro-inflammatory responses and fungal clearance [80]; on the other hand, MR signaling can upregulate IL-4 and IL-10 expression, inducing Th2 bias, leading to immunosuppression and persistent infection [81]. This bidirectional regulation indicates that MR-mediated immune effects are modulated by multiple factors, including the site of infection, fungal burden, and host microenvironment. Although the role of MR in fungal recognition and immune balance has been preliminarily established, its signaling pathways and mechanisms underlying functional bias remain insufficiently elucidated. Most current studies focus on in vitro models, lacking an integrated understanding of MR signaling dynamics across different tissue microenvironments. In particular, how MR balances Th17 and Th2 responses, and its cooperative or competitive interactions with other PRRs such as Dectin-1 or Dectin-2, remains a critical question. Future research should focus on the dynamic specificity of MR signaling and its functional shifts across infection stages, further elucidating its regulatory logic between inflammation and immune tolerance. A deeper understanding of MR-mediated immune networks may provide new strategic insights for immune interventions, chronic inflammation control, and vaccine adjuvant development in fungal infections. SIGNR-1 is a C-type lectin receptor primarily expressed on macrophages and dendritic cells, recognizing α-mannans on fungal surfaces through a calcium-dependent mechanism [82,83]. Its activation mediates p65 acetylation and induces cytokine production such as IL-12, thereby promoting Th1/Th17 responses [84,85] (Figure 2). However, the precise mechanisms underlying the role of SIGNR-1 in antifungal immunity remain unclear. Most existing studies are based on in vitro models and lack direct evidence validating its independent signaling pathway and in vivo immune functions. It is worth noting that SIGNR-1 may exhibit signal crosstalk or synergy with other PRRs, but the exact integration pattern remains unresolved. Moreover, different fungal PAMPs and host cellular environments may significantly influence its signaling output, suggesting that its function is context-dependent. Future research should focus on the downstream molecular networks mediated by SIGNR-1, its role in multireceptor cooperative recognition, and its potential involvement in balancing inflammation and immune tolerance. These efforts will provide a stronger experimental basis for evaluating the feasibility of SIGNR-1 as a target for immune intervention. Key signaling pathways, functional outputs, and immunoregulatory characteristics triggered by the recognition of fungal cell wall components by host pattern recognition receptors (PRRs). Different PRRs recognize specific fungal pathogen-associated molecular patterns (PAMPs) and activate downstream signaling molecules, including Syk, CARD9, MyD88, TRAF6, and MAPKs, thereby inducing NF-κB and/or MAPK signaling pathways and promoting the production of cytokines and chemokines involved in antifungal immunity. Dectin-1 primarily recognizes β-glucans, mannans, and chitin, activating the Syk–CARD9 axis to induce NF-κB signaling. In parallel, Dectin-1 also regulates erk- and JNK-mediated inflammatory signaling through raf-1 and PLC-2/Ca2+-dependent pathways, leading to the production of inflammatory mediators such as TNF-α, IL-6, IL-17, IL-22, and CXCL2, as well as promoting Th17 responses and neutrophil recruitment. Dectin-2 recognizes α-mannan and recruits Syk through FcRγ-ITAM signaling, thereby activating the CARD9–NF-κB pathway and inducing TNF-α and IL-12 production to promote Th17 polarization. Mincle also recognizes α-mannan and regulates the expression of pro-inflammatory and immunomodulatory cytokines through Syk-dependent signaling in a context-dependent manner. The mannose receptor (MR) recognizes α-1,2/1,3-mannan and mainly mediates immune regulation and tolerance-associated responses, including the induction of IL-4 and IL-10. SIGNR-1 recognizes α-mannan and induces p65 acetylation, thereby participating in antigen uptake and immune microenvironment modulation. TLR2 and TLR4 recognize phospholipid mannan and O-mannan, respectively, and activate NF-κB and MAPK signaling through the TIR–MyD88–TRAF6 signaling axis, thereby enhancing inflammatory responses. TLR7 and TLR9 mainly recognize fungal RNA, DNA, and chitin. TLR9 activates NF-κB and MAPK pathways through MyD88, whereas TLR7 cooperates with NOD2 and MyD88 signaling to induce cytokines such as IL-27. In addition to canonical signaling pathways, this figure further integrates the major cellular distribution, functional outputs, and recently proposed immunoregulatory mechanisms associated with different PRRs, including PRR cooperation, metabolic regulation, endosomal localization differences, and receptor crosstalk, thereby highlighting the functional heterogeneity and dynamic regulation involved in fungal immune recognition. The role and controversy of TLRs in fungal infections TLRs exhibit remarkable functional diversity in fungal recognition, among which TLR2, TLR4, TLR7, and TLR9 are considered core members of antifungal immunity [86]. TLR2 and TLR4 respectively recognize phospholipomannan and O-linked mannan on fungal surfaces and recruit MyD88 via the TIR domain to activate the TRAF6–NF-κB signaling axis, inducing proinflammatory cytokine production and T cell polarization [87] (Figure 2). In addition, small chitin particles can also activate macrophages through the TLR2–MyD88 pathway [88]. It is noteworthy that the immune effects of TLR2 signaling exhibit high plasticity. Certain fungal polysaccharides containing β-(1,6)-glucan have been reported to suppress IFN-γ production and inhibit Th1 differentiation via TLR2 [89], a finding that contrasts sharply with the classical proinflammatory role of TLR2, suggesting that its signaling is not a unidirectional amplifier of inflammation. In fact, the immune output mediated by TLR2 is highly dependent on ligand type and coreceptor composition. Studies have shown that TLR2 can form heteromeric complexes with TLR1, TLR6, or CLRs, and these complexes trigger distinct downstream signaling pathways with divergent effects on inflammation and immune regulation [90]. However, it remains unclear which ligand structural features preferentially induce immunosuppressive signaling, and how TLR2 integrates signals from multiple receptors in different cellular contexts. Thus, TLR2 signaling should be viewed as a dynamically regulated network shaped by ligand conformation, receptor complex composition, and host microenvironment, with its bidirectional modulation between inflammation and tolerance still requiring detailed elucidation. Moreover, TLR7 and TLR9 participate in antifungal responses by recognizing fungal nucleic acids or degraded cell wall components. TLR9 recognizes β-(1,3)-glucan in a Syk-dependent manner, while TLR7/TLR9 sensing of fungal nucleic acids induces type I interferon responses [91,92]. Interestingly, C. albicans can activate the TLR7/MyD88 and NOD2 costimulatory pathway to induce IL-27 secretion, and IL-27 deficiency enhances Th1/Th17 responses and fungal clearance [93]. This suggests that TLR7 and NOD2 may exert both proinflammatory and immunosuppressive functions during infection, with their crosstalk potentially determining infection outcomes. Overall, the roles of TLRs in antifungal immunity extend far beyond traditional proinflammatory defense. Their signaling outputs are determined by ligand structure, receptor crosstalk, and host immune context. Current studies still lack systematic analysis of signal bias and network integration among different TLRs. Future research should focus on: how structural variations in fungal PAMPs determine TLR signal polarization and immune outcomes; mechanisms regulating the balance between TLR-mediated immune tolerance and hyperinflammation; and the development of immune therapies or vaccine adjuvants based on precise modulation of TLR signaling. Elucidating these mechanisms will provide new theoretical insights into the immunodynamics of fungal infections and potential avenues for clinical intervention. In addition, accumulating evidence indicates that genetic polymorphisms in TLRs and their downstream signaling molecules are important determinants of interindividual differences in antifungal immune responses. Multiple population-based studies have shown that functional single nucleotide polymorphisms (SNPs) in TLR2, TLR4, and TLR9 are closely associated with susceptibility to and disease severity of invasive candidiasis, aspergillosis, and cryptococcal infection [94,95]. These variants can modulate receptor expression levels, ligand-binding capacity, or the strength of MyD88-dependent signaling, thereby influencing cytokine production and T-cell polarization [96]. Notably, the effects of different TLR variants are not uniform across fungal pathogens, indicating a pronounced pathogen-specific and context-dependent nature of their immunological roles. However, most existing studies remain largely associative, and mechanistic insights into how specific SNPs shape TLR signal integration and their crosstalk with C-type lectin receptors or NOD-like receptors are still lacking. Therefore, further investigations using larger cohorts and functional models are required to clarify how TLR genetic polymorphisms ultimately shape host immune outcomes against diverse fungal pathogens. Synergistic and complex interactions among PRRs The integration of PRR signaling represents a core feature of innate immune recognition of fungi, characterized by coordinated and antagonistic regulation among multiple receptors that collectively determine cytokine production and downstream signaling activation. Increasing evidence indicates that different PRRs do not function independently but form highly dynamic signaling networks. For example, Mincle activation can suppress Dectin-1–mediated proinflammatory responses, suggesting a balanced immune regulation between the two [78]. Mincle and other CLRs typically associate with FcRγ to form signaling complexes that activate the Syk–CARD9 pathway, mediating phagocytosis and inflammatory responses essential for fungal clearance [52,97]. In addition to membrane-bound PRRs, soluble PRRs also represent an essential component of innate immune recognition of fungi. Soluble lectins such as mannose-binding lectin (MBL), surfactant protein A (SP-A), and surfactant protein D (SP-D) can recognize mannans, β-glucans, and glycoprotein structures in the fungal cell wall, thereby enhancing pathogen uptake and clearance by phagocytes through opsonization [44,98]. Among them, SP-D not only directly binds to fungal surface ligands on A. fumigatus and C. albicans, but also cooperates with immune cell surface receptors to regulate inflammatory responses, thereby exerting a dual role in both pathogen clearance and the maintenance of immune homeostasis [45]. In addition, soluble pattern-recognition molecules such as PTX3 contribute to antifungal defense by promoting complement deposition and enhancing neutrophil recruitment. They also act in concert with membrane-bound PRRs, forming an important bridge between humoral and cellular immunity [99]. At the nucleic acid recognition level, TLR7 and TLR9 cooperate via a MyD88–IRF1–dependent pathway to detect fungal RNA and DNA, and their activation relies on phagosomal acidification and antigen processing [92]. Such cross-receptor synergy not only enhances the precision of immune recognition but also shapes the polarization of adaptive immunity. For instance, the co-recognition of β-glucan and mannan by Dectin-1 and TLR2 induces the production of PGE2, IL-6, and IL-23, driving Th17 differentiation and promoting NLRP3 inflammasome activation, thereby establishing a positive feedback loop that amplifies inflammation [100–102]. However, the molecular basis and biological significance of PRR signaling integration remain incompletely understood. Most studies still focus on linear signaling events of individual receptors, lacking systematic modeling of dynamic multi-PRR networks. Moreover, the coordination between Dectin-1 and TLR pathways in phagosome maturation, ROS generation, and metabolic reprogramming remains unclear, making it difficult to explain context-dependent immune responses to different fungi or host backgrounds. Critically, the “double-edged sword” effect of membrane-bound and soluble PRRs in maintaining immune homeostasis and preventing excessive inflammation has not yet been fully elucidated. Future studies should aim to define the spatial and temporal characteristics of multi-PRR signaling complexes and uncover their cooperative regulation of immune metabolism and inflammasome activation. Exploring therapeutic strategies targeting PRR crosstalk to achieve immune balance may provide a novel avenue for clinical intervention. A systematic understanding of these signaling networks will not only help explain the immunological heterogeneity observed in fungal infections but also lay a theoretical foundation for precision immunotherapy based on PRR modulation. The role and controversies of gal-3 in fungal infections It is worth noting that although Gal-3 has been shown to participate in pathogen recognition and immune regulation in a variety of fungal infections, it does not belong to the classical CLR family. Unlike Dectin-1, Dectin-2, Mincle, and the mannose receptor, which are Ca2+-dependent and contain canonical C-type lectin domains, Galectin-3 is a member of the S-type lectin family and primarily mediates cell–cell interactions and immune modulation through recognition of β-galactoside–containing structures [103]. Gal-3 is a glycan-binding protein broadly expressed in macrophages, dendritic cells, natural killer cells, and activated T/B cells [104,105]. It primarily recognizes β-(1,2)-mannose residues on fungal surfaces and mediates phagocytosis [106,107]. The carbohydrate recognition and phagocytic functions of Gal-3 are mainly dependent on M2-type macrophages, while its activity in M1-type macrophages is relatively low [108], indicating subtype-specific immune regulation. Unlike classical innate lectins, Gal-3 not only participates in opsonization and phagocytosis but also exhibits direct fungicidal activity against certain opportunistic fungi such as C. albicans [109]. However, whether this effect depends on its carbohydrate recognition domain (CRD) remains controversial, and in vivo evidence supporting its independent antifungal role is still lacking. Meanwhile, Gal-3 can modulate local cytokine milieus to influence CD4+ T cell differentiation, but its regulatory direction on Th1 and Th17 responses varies significantly across different infection models [110], highlighting its strong context dependency. Overall, the mechanisms underlying Gal-3 function in fungal infections remain poorly defined. Its functional divergence in M1/M2 macrophages, potential direct fungicidal capacity, and plasticity in adaptive immune regulation all require systematic investigation. Future research should focus on elucidating the upstream and downstream interactions and dynamic regulation of its signaling pathways to clarify the integrative role of Gal-3 in inflammation modulation, immune tolerance, and antifungal defense, thereby providing new directions for targeted immune intervention. In addition, beyond the lectin receptors described above, recent studies have identified a variety of lectin-like receptors involved in the regulation of host antifungal immunity. For example, DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin) can recognize fungal cell wall mannans and modulate inflammatory responses in dendritic cells [111]. MelLec (CLEC1A) has been identified as a pattern recognition receptor that specifically recognizes DHN-melanin on A. fumigatus conidia and mediates protective host immunity against aspergillosis. Furthermore, genetic polymorphisms in CLEC1A are associated with an increased susceptibility to invasive aspergillosis in hematopoietic stem cell transplant recipients [112]. In contrast, CLEC12A primarily recognizes damage-associated molecular patterns (DAMPs). Recent studies suggest that it may also participate in antifungal inflammatory responses and the maintenance of tissue immune homeostasis [113], although the underlying mechanisms remain to be fully elucidated. Therefore. this review focuses on the relatively well-characterized classical receptors, including Dectin-1, Dectin-2, Mincle, and MR. The role of dendritic cells (DCs) in fungal infection DCs serve as a crucial bridge between innate and adaptive immunity during fungal infection. By recognizing fungal cell wall components and presenting antigens, they initiate CD4+ and CD8+ T-cell responses [114]. Mature DCs highly express PRRs, including CLRs and TLRs, enabling them to sense carbohydrate antigens such as mannans and glucans and to trigger immune activation. Through the secretion of cytokines and co-stimulatory molecules, DCs not only promote Th1 and Th17 polarization to enhance antifungal defense but also modulate Treg activity to maintain immune homeostasis. Additionally, they cooperate with neutrophils and macrophages in pathogen phagocytosis and clearance. However, DC functions display high plasticity. Variations in fungal species and PAMP structures can markedly influence T-cell polarization outcomes. Certain DC subsets may preferentially induce anti-inflammatory Treg or Th2 responses when recognizing β-glucans with distinct chain lengths or branching patterns [114,115]. This observation indicates that current understanding of DC-driven T-cell polarization remains incomplete. Most studies still rely on in vitro models and lack systematic in vivo validation. In particular, the relationship between DC subset identity, ligand recognition spectrum, and immune output has not been fully elucidated, limiting the precision of vaccine and immunotherapy design. Therefore, future studies should focus on the subset-specific recognition mechanisms of DCs and their functional dynamics across different infection contexts, clarifying their role in balancing immune activation and tolerance. This will not only deepen the mechanistic understanding of immune regulation in fungal infections but also provide theoretical guidance for the development of DC-based vaccines and immunomodulatory strategies. The role of natural killer (NK) cells in fungal infection NK cells have long been regarded as “early responders” in fungal infection, capable of recognizing fungal-associated molecules or stress-induced host ligands via NKp30, NKp46, and NKG2D, and mediating cytotoxicity through the release of perforin, granzymes, and IFN-γ [116]. However, this classical view is overly simplistic. Fungal cell walls lack the “missing-self” signals typical of viral or tumor cells, meaning that NK activation often occurs indirectly through cytokines such as IL-12 and IL-18 secreted by DCs or monocytes [117]. This network-dependent activation renders NK functions highly sensitive to microenvironmental cues, whereas most in vitro studies examine NK cells in isolation, overlooking intercellular signaling cooperation – resulting in inconsistent and poorly reproducible findings. Moreover, NK cell activity exhibits strong context dependence across different fungal infections. In A. fumigatus infection, NK cells can directly damage hyphae via perforin-mediated mechanisms [118]. In contrast, during C. neoformans infection, NK cells display a suppressive phenotype driven by the capsular polysaccharide GXM, which downregulates NK activating receptors and induces apoptosis [119]. These findings highlight fungal strategies for actively modulating host immunity and indicate that NK cells are not uniformly protective; in chronic or latent infections, they may contribute to immune tolerance or evasion. In recent years, with the development of chimeric antigen receptor (CAR) technology, engineered CAR-NK cells have also been explored as a potential strategy for targeting fungal infections. Compared with natural NK cells that rely on endogenous PRRs, CAR-NK cells can directly bind fungal cell wall antigens – such as β-glucans or mannose-associated epitopes – through artificially designed recognition domains, thereby bypassing host innate immune signaling pathways and achieving more stable activation [120]. Some studies have attempted to construct CAR-NK cells using Dectin-1 or its derivatives as recognition domains to enhance antifungal activity against Aspergillus species [121]. However, current research remains largely at the in vitro or proof-of-concept stage, and the efficacy and safety of CAR-NK therapy in authentic infection settings have yet to be systematically evaluated. In particular, given the dynamic nature of fungal cell wall composition and its immunomodulatory properties, CAR-NK–based approaches may face challenges such as unstable target antigen exposure, excessive inflammatory responses, and potential tissue damage. Therefore, although CAR-NK therapy represents a promising immunotherapeutic strategy for targeting fungal cell walls, its clinical translation will require further validation with respect to antigen selection, microenvironmental adaptability, and safety control. Although β-glucans have been proposed to influence NK functions via Dectin-1 [116], current evidence is limited and largely derived from high-dose stimulation or in vitro assays, lacking validation under physiological conditions or within infection microenvironments. Thus, the classification of NK cells as effectors of “trained immunity” remains hypothetical and should not yet be considered a core concept. Overall, existing studies on NK antifungal immunity suffer from structural bias – overemphasizing their immunoenhancing potential while neglecting their dual roles in immune homeostasis, tissue injury, and fungal immune evasion. There is also a lack of frameworks integrating systemic immunity, microenvironmental regulation, and temporal dynamics to assess NK functional plasticity. Future research should situate NK cells within the tripartite context of fungus–host–microenvironment interactions and employ multi-omics and spatiotemporal single-cell approaches to redefine their genuine role in antifungal immunity – moving beyond the traditional cytotoxicity-centered paradigm. The role of the complement system in fungal infections In addition, the complement system, as a fundamental component of innate immunity, plays a pivotal role in the early host defense against fungal infections. Mannans within the fungal cell wall can be recognized by mannose-binding lectin (MBL), thereby initiating the lectin pathway. When inner-layer β-(1,3)-glucan becomes exposed as a result of fungal growth, environmental stress, or antifungal treatment, it can also promote activation of the alternative pathway, ultimately leading to C3 cleavage and C3b deposition on the fungal surface, thereby enhancing complement-mediated opsonization and phagocytic clearance by host immune cells [122]. Notably, the efficiency of complement activation is markedly influenced by fungal species, developmental stage, and the extent of cell wall component exposure. For example, in C. albicans, the intact outer mannan layer masks the underlying β-glucan, thereby reducing activation of the alternative pathway, whereas cell wall remodeling or echinocandin-induced β-glucan exposure enhances complement deposition [122,123]. However, complement activation does not necessarily result in effective pathogen clearance. A growing body of evidence indicates that fungi have evolved multiple strategies to evade complement-mediated immunity, including the recruitment of host complement regulatory proteins, such as Factor H and C4b-binding protein (C4BP), the secretion of proteases that degrade complement components, and the masking of cell wall ligands to reduce complement recognition. Together, these mechanisms attenuate complement-mediated opsonophagocytosis and inflammatory responses [122]. Furthermore, although complement activation products such as C3a and C5a promote leukocyte recruitment and immune activation, persistent or excessive complement activation may also contribute to host tissue damage and, in certain mucosal environments, sustain chronic inflammation or disrupt host–fungus homeostasis [124]. Accordingly, an increasing number of studies suggest that the role of the complement system in antifungal immunity is highly context dependent. Its biological effects are jointly determined by dynamic fungal cell wall remodeling, the site of infection, the host immune status, and the regulatory network governing complement activation, rather than functioning solely as a protective immune mechanism. Future studies are needed to further elucidate the dynamic interactions between the complement system and other innate immune recognition pathways, thereby providing a more comprehensive understanding of its immunoregulatory roles in different fungal infections. The response of adaptive immune cells to the cell walls of fungi T-cell immune response Fungal cell wall components activate antigen-presenting cells (APCs) through PRRs, inducing the expression of costimulatory molecules and specific cytokines that determine the differentiation of naïve CD4+ T cells into distinct Th subsets (Th1, Th2, Th17, Treg, etc.) [115]. The differentiated T cells then exert effector functions by secreting characteristic cytokines, effectively restricting fungal proliferation and dissemination within the host. Th1 cells Upon recognition of fungal antigens, APCs induce T-bet expression via IL-12 signaling, driving Th1 differentiation [125]. In this process, APCs recognize polysaccharide structures in the fungal cell wall, such as β-1,3-glucans, mannans, and their associated protein complexes. Through coordinated signaling mediated by CLRs (such as Dectin-1 and Dectin-2) and TLRs, APCs shape an IL-12–dominated cytokine milieu that promotes Th1 polarization [126]. IFN-γ derived from Th1 cells plays a central role in early antifungal responses by activating macrophages, enhancing B-cell antibody production, and promoting pathogen clearance through the regulation of NO and ROS generation [127–130]. In addition, IFN-γ can induce IDO expression in dendritic cells and neutrophils, balance the IL-12/IL-10 axis, and cooperate with Treg responses to limit excessive inflammation [131,132]. These findings establish Th1 responses as pivotal for maintaining both protective immunity and immune homeostasis. However, significant structural limitations remain in current research. Most evidence for Th1-mediated protection derives from murine models and in vitro systems, and its reproducibility and translational relevance in complex human infections are still uncertain. The immunological context, varying by fungal species and infection sites, leads to highly context-dependent protective or pathogenic effects of IFN-γ. In some infections, excessive Th1 activation can even exacerbate tissue inflammation and immunopathology [133], underscoring the “double-edged sword” nature of IFN-γ. Second, the mechanisms by which structural heterogeneity of fungal cell wall polysaccharide antigens influences Th1 polarization have not yet been systematically elucidated. Features such as polysaccharide conformation, branching density, and adjuvant formulation may all affect antigen presentation and T-bet activation, yet existing studies largely remain empirical, lacking a systematic understanding of the molecular recognition–signaling–polarization cascade. In addition, variations in antigen extraction or chemical modification often yield inconsistent immune outcomes, limiting the predictability of vaccine design. This uncertainty likewise constrains the development of engineered immunotherapeutic strategies targeting fungal cell wall antigens. For example, the efficacy and stability of CAR-T cells designed against β-glucan – or mannan-associated epitopes may be highly dependent on the accessibility of these target antigens at different stages of fungal growth and across distinct infection sites. Overall, while Th1 responses are broadly recognized as a key component of protective antifungal immunity, their effects are not linear or unidirectional but rather modulated by antigen structure, microenvironmental cues, and intercellular communication. Future studies should integrate systems immunology and single-cell multi-omics approaches to dissect the dynamic networks governing Th1 polarization, evaluate the balance between IFN-γ–mediated tissue protection and damage, and elucidate how fungal polysaccharide architecture determines the plasticity of Th1 responses. Th2 cells Th2 cells secrete cytokines such as IL-4, IL-5, IL-10, and IL-13 and are traditionally recognized for their protective roles in parasitic infections and immune regulation. However, in the context of fungal infections, Th2 polarization is typically associated with immunosuppression and disease progression [134,135]. Studies have shown that in Cryptococcus and Aspergillus infections, Th2-type immunity often correlates with worsened clinical outcomes [136,137]. IL-4 can inhibit IFN-γ production, weaken delayed-type hypersensitivity (DTH), and promote the generation of non-protective antibodies (e.g. IgE, IgG4) and eosinophil proliferation, suggesting that Th2 bias may contribute to fungal dissemination and poor prognosis [138]. In these contexts, the spatial masking of fungal cell wall polysaccharides – such as the coverage of β-glucans by α-glucans or capsular structures – may attenuate Th1/Th17-associated signaling while relatively enhancing Th2-biased immune pathways [8,139]. Nevertheless, recent evidence indicates that Th2 responses are not purely “harmful.” IL-4 and IL-10 may, at certain stages of infection, help maintain immune homeostasis by restraining excessive inflammation or indirectly promoting Th1-associated factors [140]. Some studies even report that specific Th2-related antibodies can partially reduce the virulence of encapsulated spores, indicating a potential regulatory defense function [140]. This dual “suppressive–protective” nature highlights a key concept: the immune outcome of fungal infections depends more on the dynamic balance between Th1 and Th2 responses than on the strength of a single subset. Current research overly relies on murine models or in vitro stimulation systems, often overlooking how fungal species, infection stage, and host immune background shape Th2 functionality. Moreover, most experiments use high-dose antigen stimulation, which poorly reflects immune regulation during chronic or latent infections. Notably, the mode and timing of fungal cell wall antigen presentation may play a critical role in determining the persistence and reversibility of Th2 responses. This has important implications for engineered immunotherapeutic strategies targeting cell wall antigens: if the antigen recognized by CAR-T cells is predominantly associated with structures that induce Th2-biased immunity, the resulting immune efficacy may be constrained by the local immunosuppressive microenvironment. Future research should focus on elucidating the temporal regulation of Th2 responses, especially their differential roles during early and chronic infection phases; integrate metabolic and epigenetic perspectives to uncover how IL-4/IL-10 signaling modulates immune homeostasis and fungal persistence; and reconsider therapeutic strategies – rather than simply suppressing Th2 responses, efforts should aim to balance their “suppressive” and “protective” effects for precise immune modulation. In summary, Th2 responses in antifungal immunity should not be simplistically categorized as “suppressive,” but redefined as dynamic regulators that shape the magnitude and direction of immune responses in a context-dependent manner. This perspective offers important insights for designing targeted antifungal immunotherapies. This understanding underscores that, in immunotherapeutic strategies targeting fungal cell wall antigens, both the structural characteristics of the antigens and the T-cell polarization patterns they elicit must be taken into consideration. Th17 cells During fungal infection, APCs induce the differentiation of CD4+ T cells into Th17 subsets by secreting proinflammatory cytokines such as IL-1β, IL-6, and IL-23. This process is typically initiated by the recognition of β-1,3-glucans and related structures in the fungal cell wall by antigen-presenting cells, particularly through CLRs such as Dectin-1–mediated signaling [141]. Among them, IL-6 and IL-23 promote Th17 maturation by upregulating the transcription factor RORγt [127,142], while TCR signaling can further enhance this process through NFAT, NF-κB, and AP-1 pathways [143]. Mature Th17 cells primarily secrete IL-17 and IL-22, activating epithelial cells, fibroblasts, and macrophages to release chemokines, AMPs, and matrix metalloproteinases, thereby strengthening neutrophil recruitment and mucosal barrier defense [127]. This defensive axis is particularly prominent during mucosal infections in which β-glucans are sufficiently exposed, highlighting the critical role of cell wall accessibility in determining Th17-mediated immune responses [144]. Extensive animal studies confirm that Th17 responses are essential for mucosal antifungal immunity. For instance, in models of Candida or Aspergillus infection, mice deficient in IL-17 signaling exhibit reduced neutrophil infiltration, increased fungal burden, and downregulated chemokine expression [145]. Similarly, IL-17–mediated responses are also indispensable for mucosal defense against the emerging multidrug-resistant fungus C. auris [146]. However, this protective role is not universal. The IL-17 response exhibits notable duality: it restricts fungal dissemination during early localized infections but, when overactivated in systemic or chronic infections, often leads to tissue damage and immunopathology [147]. This “protection–pathology” paradox suggests that sustained or nonspecific activation of the β-glucan–Th17 axis may, once fungal burden is controlled, instead amplify inflammatory responses. Moreover, current studies on Th17 responses face clear limitations. Most rely on murine models or high-dose antigen stimulation, which fail to replicate the true immune dynamics of human chronic infections or immunocompromised conditions. Notably, fungi can dynamically modulate the intensity of Th17 responses by altering cell wall remodeling patterns at different growth stages – such as through the masking or re-exposure of β-glucans – an aspect that is often underestimated in current models. Future research should aim to elucidate the molecular mechanisms that balance IL-17–mediated protection and tissue injury; explore optimal modes of Th1/Th17 co-induction to guide next-generation antifungal vaccine design; and validate the dynamic roles and plasticity of Th17 responses across infection stages using humanized models and clinical samples. At the same time, these insights have direct implications for the design of CAR-T cells targeting β-glucans or related epitopes: how to enhance mucosal defense while avoiding IL-17–driven immunopathology will be a key challenge for the clinical translation of such strategies. In conclusion, Th17 responses represent both a key driver of mucosal defense and a potential amplifier of inflammation during fungal infection. A deeper understanding of their regulatory networks and context dependency will be essential for achieving precision antifungal immune intervention. Treg cells Regulatory T cells (Tregs) are key immune cells responsible for maintaining immune homeostasis, primarily by suppressing excessive immune responses and preventing tissue damage. Tregs can be divided into thymus-derived (tTregs) and peripherally induced (iTregs) subsets, with iTregs playing particularly important roles in antifungal defense. The expression of their signature transcription factor Foxp3 is regulated by cytokines such as TGF-β and IL-10 and influenced by the PI3K–mTOR–AKT signaling pathway, which is essential for Treg differentiation and functional stability [148–150]. Previous investigations have suggested that the sensing of certain fungal cell wall polysaccharides – such as mannans or masked β-glucan structures – by antigen-presenting cells tends to induce a TGF-β/IL-10–dominated immunological milieu, thereby promoting the generation of Foxp3+ iTregs [89,148,151]. Tregs mediate immune regulation through multiple mechanisms, including the secretion of immunosuppressive factors (e.g. IL-10, TGF-β, IL-35) to directly suppress inflammation, induction of APC apoptosis via perforin and granzyme B, and inhibition of dendritic cell maturation and T-cell activation, thereby promoting the differentiation of naïve T cells into Tregs [152,153]. Moreover, by consuming IL-2 and modulating the expression of transcription factors such as T-bet, IRF4, and RORγt, Tregs restrain excessive Th1, Th2, and Th17 responses, reduce tissue inflammation, and maintain immune tolerance [154–156]. However, Treg functions exhibit high plasticity. In certain fungal infection contexts, Tregs may suppress protective immune responses and delay pathogen clearance [157]. This duality suggests that the balance between “preventing immunopathology” and “inhibiting protective immunity” may determine infection outcomes. Currently, there remains a lack of systematic understanding regarding the dynamic changes in Treg function during different infection stages and the reciprocal regulation within the Th17/Treg axis. Therefore, future studies should focus on elucidating the functional polarization of Tregs across diverse infection environments and their interactions with effector T cells. It is particularly important to note that, in immunotherapeutic strategies targeting fungal cell wall antigens – including CAR-T–based approaches – local enrichment of regulatory T cells and the presence of immunosuppressive signals may substantially affect therapeutic efficacy. This issue has not yet been adequately addressed in current studies of antifungal immunotherapy. This will not only advance our understanding of immune balance during fungal infection but also provide theoretical foundations for developing precise immunomodulatory strategies. B-cell immune responses During fungal infection, B cells are activated upon recognizing fungal antigens through surface immunoreceptors, subsequently differentiating into plasma cells and secreting specific antibodies. These antigens are primarily derived from exposed polysaccharide and glycoprotein structures in the fungal cell wall, including β-glucans, mannans, and their associated composite epitopes [133]. These antibodies exert antifungal functions by neutralizing pathogens, activating complement, promoting phagocytosis, and mediating antibody-dependent cellular cytotoxicity. Additionally, they inhibit fungal adhesion, hyphal growth, and biofilm formation, thereby restricting infection dissemination [158]. However, the antifungal role of humoral immunity extends far beyond these classical mechanisms. Some studies have shown that fungus-specific antibodies (e.g. CAGTA) can directly alter the metabolic state and cell wall structure of Candida, inducing fungal death [159], while antibodies targeting β-glucan exhibit cross-species recognition of multiple fungi, providing broad protection by enhancing neutrophil activation and inhibiting adhesion [158,160]. These findings suggest that antibodies act not only as “immune markers” but also as direct modulators of fungal physiology. Despite the promising potential of antibody-mediated antifungal immunity, major challenges remain from basic mechanisms to clinical translation. First, fungal antigens exhibit a high degree of structural heterogeneity, particularly with respect to the spatial conformation and glycan modifications of cell wall polysaccharides, which can vary substantially among different strains and even across different growth stages of the same pathogen. This heterogeneity makes it difficult to achieve both broad-spectrum coverage and high specificity simultaneously. Second, most existing studies rely on in vitro systems and lack validation in complex host environments. Antibody efficacy often depends on cooperation with complement and phagocytes, yet the signaling crosstalk among these components remains poorly understood. Furthermore, while mucosal IgA has shown protective effects in some models [161], its true contribution in fungal infections remains controversial. A major limitation of current research lies in its narrow “antigen–antibody” linear perspective, overlooking the role of antibodies as integrators of innate and adaptive immunity. Through Fc receptor–mediated signaling, antibodies may regulate the polarization of dendritic cells and macrophages, thereby indirectly shaping Th1 and Th17 responses [162]. This cross-system regulatory mechanism remains underappreciated in antifungal research. This characteristic also provides important insights for engineered immunotherapeutic strategies. Unlike CAR-T or CAR-NK cells, antibody-mediated effects rely on cooperation between the Fc region and the host immune system, and their functional stability is therefore constrained by both antigen exposure patterns and the surrounding immune microenvironment. In addition, structural and functional optimization of antibodies – including Fc glycosylation, affinity maturation, and delivery system improvement – is critical for clinical feasibility. Future studies should aim to elucidate the molecular basis of antibody–innate immune synergy and define the stage-specific functions of antibodies during infection. Systematic evaluation of fungal antigen diversity and its impact on antibody efficacy is also needed, alongside the development of broad-spectrum targeting strategies based on conserved structural domains. Establishing clinically relevant models will be essential for assessing the safety and efficacy of antibody therapies in immunocompromised hosts. In summary, B-cell–mediated humoral immunity in fungal infection exhibits both protective and regulatory roles, with its functional outcome shaped by the complexity of fungal antigens and the host immune environment. The conceptual transition from viewing antibodies as mere “immune markers” to recognizing them as active “immunoregulatory effectors” marks a pivotal shift – signaling that antifungal humoral immunity is advancing from descriptive understanding toward mechanistic and translational innovation. Immune memory Following fungal infection, T and B cells within the adaptive immune system are activated and differentiate into effector and memory subsets, establishing long-term immune protection after primary pathogen clearance. Studies have shown that a subset of effector CD4+ T cells can transition into long-lived memory T cells that rapidly recognize antigens and initiate immune responses upon reinfection. Their formation is influenced by early innate immune signals – for example, TLR2 agonists induce higher survival rates of memory T cells compared to TLR4 agonists [163]. Upon reinfection, these memory T cells can quickly secrete IFN-γ and IL-17: the former activates macrophages to enhance fungicidal activity, while the latter promotes neutrophil recruitment, together facilitating efficient fungal clearance [164,165]. Additionally, CD4+ memory T cells can promote B-cell differentiation into plasma cells through CD40L and IL-21 signaling, leading to the production of fungus-specific antibodies – thereby forming a functional bridge between cellular and humoral immunity [166]. This mechanism represents a key immunological foundation for vaccine-induced protection. At the humoral level, B cells generate memory B cells following primary infection, which can rapidly differentiate into high-efficiency plasma cells upon secondary exposure, secreting high-affinity antibodies to strengthen defense. Memory B cells targeting fungal cell wall β-glucan can rapidly produce broadly cross-reactive antibodies, suggesting their potential in counteracting fungal diversity [133]. However, the high variability of fungal antigens and complex glycan modifications remain major bottlenecks in achieving broad-spectrum immunity – a challenge particularly critical for vaccine design. Beyond classical adaptive immunity, the concept of “trained immunity” provides a new perspective on antifungal defense. This mechanism primarily occurs in the monocyte/macrophage lineage and is triggered by fungal components (such as β-glucan) via PRRs (e.g. Dectin-1), inducing epigenetic reprogramming (such as histone methylation and acetylation) that enhances responsiveness to secondary infections [167,168]. For instance, β-glucan–trained monocytes can activate the RAF1 pathway, leading to markedly increased secretion of IL-1β and TNF-α, as well as enhanced phagocytic and fungicidal capacity [164,168]. Clinically, this form of “nonspecific memory” is thought to contribute to protection against recurrent fungal infections. Notably, certain fungi, such as C. auris, can evade host recognition by reducing β-glucan exposure on their cell walls, thereby weakening trained immunity. Although direct evidence is still lacking regarding whether C. auris can induce or activate adaptive memory, multiple studies suggest that trained and adaptive immunity may act synergistically to strengthen antifungal defense. Therefore, integrating “innate trained immunity” with “T/B-cell memory” within vaccine strategies may represent a promising approach for achieving broad, durable antifungal protection. Although existing research has revealed the multilayered mechanisms of immune memory during fungal infection, most evidence remains derived from in vitro or animal studies, lacking systematic tracking of T- and B-cell memory dynamics and function in human infection. The synergistic relationship between adaptive and trained immunity remains to be fully modeled, with its temporal regulation, tissue specificity, and signaling crosstalk still poorly defined. Moreover, the high heterogeneity of fungal infections – across infection sites and host immune conditions – may lead to substantial variation in the quality and durability of immune memory. Future studies should move beyond single-cell descriptions and employ multi-omics and systems immunology approaches to elucidate the network-level regulation of immune memory following fungal infection, thereby providing a theoretical foundation for vaccine development and immunotherapeutic interventions. In vivo immune responses to fungal infections: species-specific patterns Although increasing attention has been devoted to host immune responses to fungal infections in vivo, current understanding remains limited in several respects. On the one hand, most studies are based on specific animal models or single infection conditions, which restricts the comparability of findings across different fungal species, infection sites, and host immune states. On the other hand, definitions of T helper cell subsets and their associated cytokine functions vary among studies, and in some cases even yield contradictory results. Therefore, an integrated, species-level analysis of fungus-induced immune responses remains necessary. Existing in vivo studies generally suggest that different pathogenic fungi elicit distinct T helper cell differentiation patterns. For example, C. albicans infection is commonly associated with Th17-type immunity, with IL-17 and IL-22 contributing to neutrophil recruitment and maintenance of mucosal barrier integrity [169]. In contrast, A. fumigatus infection more frequently induces a Th1-biased response, in which IFN-γ and IL-12 play critical roles in restricting fungal growth [170,171]. However, such classifications are not absolute, as infection dose, host genetic background, and immune status can all substantially influence T-cell polarization. For example, Cryptococcus infection is typically characterized by a Th2-skewed immune environment, accompanied by altered levels of IL-4 and IL-13. This immune profile is often associated with impaired fungal clearance and disease progression [172]. Nevertheless, some studies indicate that under certain conditions, Th1 responses can still confer protection against Cryptococcus, highlighting the strong context dependency of its immunoregulatory mechanisms [173]. For dimorphic fungi such as Histoplasma and Paracoccidioides, Th1- or Th17-mediated cellular immunity is generally considered essential for infection control, whereas a Th2-biased response is often associated with chronic or disseminated disease [174,175]. It should be noted, however, that most available data are derived from animal models, and systematic analyses of cytokine dynamics in human infections remain limited. In addition, different fungi shape the local immune microenvironment by inducing distinct chemokine profiles – such as CXCL1, CXCL2, CXCL9/10, or CCL2 – thereby regulating the recruitment of neutrophils, monocytes, and T cells [176]. Nevertheless, studies systematically correlating chemokine patterns with disease severity, fungal burden, and immune outcomes are still lacking [177,178]. Overall, current evidence supports the existence of species-specific immune response patterns in fungal infections, however, their regulatory mechanisms and clinical relevance require further clarification through comprehensive in vivo investigations. Noninfectious interactions between fungi and the Host Fungal allergens and allergic responses Beyond infection, increasing attention has been paid to the roles of fungal cell wall components in allergic and immune-mediated diseases, particularly in the context of asthma and inflammatory bowel disease (IBD) [179]. Multiple studies have shown that β-glucans, mannans, and chitin fragments can act as important environmental or mucosal exposure factors. These components not only activate innate immune responses but also indirectly shape adaptive immunity. Especially in the T-cell responses, they are influencing antigen presentation and the local cytokine milieu, thereby contributing to the development of fungal-associated allergic and inflammatory diseases [180]. However, in contrast to bacterial PAMPs, fungal cell wall components induce heterogeneous T-cell responses across different disease models, and in some cases even contradictory outcomes have been reported [181]. In airway allergic diseases such as asthma, β-glucans are generally considered pro-inflammatory and can activate dendritic cells and macrophages via receptors such as Dectin-1, thereby influencing T-cell polarization [182]. On the one hand, several studies have shown that β-glucan exposure enhances airway inflammation and promotes Th2- or Th17-type immune responses, exacerbating airway hyperresponsiveness [183]. On the other hand, under certain conditions – depending on dose, structure, or route of exposure—β-glucans have been reported to induce IL-10 production and Treg-associated pathways, thereby suppressing Th2-mediated allergic responses [184]. These discrepancies are likely related to differences in β-glucan structure (β-1,3 vs β-1,6 linkages), particle size, mode of administration, and host immune background; however, systematic comparative studies are still lacking. Chitin likewise exhibits strong context dependency in fungal allergy and IBD models. Low–molecular weight chitin fragments have been reported to promote Th2-skewed immune responses by inducing cytokines such as IL-4, IL-5, and IL-13, and are associated with exacerbated asthma-like or intestinal inflammation [60]. In contrast, larger chitin particles may limit inflammation by modulating antigen-presenting cell function and promoting Treg responses or weaker T-cell activation [185]. These findings suggest that chitin is neither inherently pro- nor anti-allergenic; rather, its immunological effects depend heavily on physical properties, tissue context, and the local inflammatory milieu. However, the underlying molecular mechanisms remain incompletely understood. By comparison, mannans and mannoproteins are more consistently regarded as key antigens in sensitization and immune modulation. They can be recognized by dendritic cells via multiple CLRs, thereby influencing antigen processing and presentation and, in certain contexts, promoting Th2-type immune responses – an association reported in asthma and subsets of IBD patients [186]. Nevertheless, whether mannans act as direct drivers of T cell–mediated pathology remains insufficiently supported by functional evidence. Overall, current studies on the roles of fungal cell wall components in asthma, IBD, and other immune-mediated diseases have largely focused on correlations with disease phenotypes or T-cell polarization patterns. Systematic comparisons integrating antigen type, dose, exposure route, and corresponding T-cell responses (e.g. Th2, Th17, or Treg) remain limited. This lack of standardized experimental frameworks likely contributes to the heterogeneity and controversy observed in this field. Fungal Commensalism/Colonization and Host immune homeostasis Under noninfectious conditions, fungi constitute an integral component of the host microbiota, and their cell wall components continuously interact with the host immune system at low levels. Unlike infectious or allergic contexts, β-glucans, mannans, and chitin generally do not elicit strong inflammatory responses during commensalism or colonization, but instead contribute to the maintenance of immune homeostasis. Importantly, this “immune tolerance” is not a passive process but rather a dynamically regulated state. Accumulating evidence suggests that commensal fungi limit immune activation by modulating the exposure of their cell wall components. For example, the masking effect of outer-layer mannans on inner β-glucans and chitin is considered a key mechanism by which fungi reduce persistent activation of receptors such as Dectin-1 [185]. This structural regulation highlights that the fungal cell wall is not merely a passive target of immune recognition, but an active participant in immune modulation. Nevertheless, current knowledge regarding fungal cell wall components under commensal conditions remains limited. On the one hand, most studies rely on model fungi or in vitro systems, which may not accurately reflect the complexity of fungal communities and cell wall heterogeneity within the native microbiota. On the other hand, host immune responses to commensal fungi are not entirely static. Evidence indicates that even under homeostatic conditions, β-glucans and chitin can induce low-level innate or adaptive immune activation. Whether this “background stimulation” is protective or potentially pathogenic remains unresolved. Consequently, our current understanding of fungal cell wall components in commensal immunity remains largely conceptual. These molecules are neither purely immunologically silent nor equivalent to classical pathogen-associated molecular patterns. Instead, they exist along a continuum between immune activation and tolerance. This ambiguity reflects a central unresolved question in fungal immunology: how the host discriminates, at the molecular level, between commensal fungi and potentially pathogenic species. Summary The fungal cell wall serves as the critical interface between the pathogen and the host immune system, determining not only the specificity of immune recognition but also shaping the immunological outcomes of infection. Its dynamic remodeling and structural plasticity are central to fungal adaptation and immune evasion, while simultaneously posing major challenges to host recognition and immune regulation. Innate immune cells sense fungal polysaccharides through diverse PRRs, triggering complex signaling cascades and intercellular interactions that lay the foundation for adaptive immune responses. However, this recognition network is not a unidirectional linear process; rather, it represents a dynamic system modulated by multilayered negative feedback and immune crosstalk. In addition, epithelial cells, as the first barrier encountering fungi, also participate in immune regulation by expressing PRRs and secreting AMPs and inflammatory mediators. Meanwhile, the complement system can directly recognize fungal cell wall components and cooperates to promote opsonophagocytic and inflammatory responses, thereby further shaping the early antifungal immune environment. Different fungal species and infection sites can drive immune responses from protective to pathological, underscoring the intricate balance between defense and damage in antifungal immunity. At the adaptive level, the functions of Th1, Th17, Treg, and B cells exhibit pronounced temporal dependence and heterogeneity. Tregs display a “double-edged sword” effect, simultaneously suppressing immunopathology while potentially limiting fungal clearance. Meanwhile, B-cell–mediated humoral immunity not only provides antibody-dependent protection but can also regulate innate immune cell polarization through Fc receptor signaling. Recent studies on immune memory further suggest that T/B-cell memory and innate trained immunity together constitute a multilayered memory network that, under specific conditions, cooperatively enhances host defense. This cross-level immune integration offers new conceptual and translational opportunities for vaccine design and immunotherapy. Notably, fungi can also persist in the host as commensal components, and dysregulation of their immune recognition may shift immune homeostasis from tolerance toward allergic inflammation characterized by Th2 polarization and IgE responses, further highlighting the dual nature of antifungal immune regulation. Despite recent advances, major gaps remain in understanding immune recognition and regulation during fungal infection. How does the structural plasticity of the fungal cell wall fine-tune PRR signaling? How do immune cells integrate signals to dynamically balance defense and tolerance? What are the temporal and functional coupling mechanisms between trained and adaptive immunity? Addressing these questions will not only refine the theoretical framework of antifungal immunity but also facilitate the development of personalized immunomodulatory and vaccine strategies. Future research should move beyond single receptor–ligand paradigms toward integrated systems immunology and multi-omics approaches to capture the dynamic landscape of fungus–host interactions. Efforts should focus on delineating immune network remodeling and cell fate decisions across infection stages, and on establishing quantifiable immune biomarkers to evaluate the efficacy of immunotherapies and vaccines. Bridging the gap from molecular mechanisms to systemic regulation, and from animal models to clinical applications, will be essential for achieving precise immune control of fungal infections. Acknowledgements R.W. wrote the initial draft. X.Y.P., W.Q.L., Z.Y.S, and H.Y. edited the final draft. All the authors have read and approved the manuscript. Funding Statement This research was supported financially by the Science and Technology Project of Sichuan [25NSFSC0602], and the Technology Strategic Cooperation Project of Luzhou Municipal People’s Government–Southwest Medical University [2023LZXNYDJ014]. Disclosure statement No potential conflict of interest was reported by the author(s). Data availability statement Data availability is not applicable to this article as no new data were created or analyzed in this study. References Associated Data Data Availability Statement Data availability is not applicable to this article as no new data were created or analyzed in this study.